CRL-42872
CRL-42872 is an orally active, highly bioavailable Gp IIb/IIIa platelet receptor inhibitor. CRL-42872 inhibits the binding of fibrinogen to the Gp IIb/IIIa receptor, thereby suppressing collagen-induced platelet aggregation. CRL-42872 is widely used in thrombosis-related studies.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 256385-24-7
- 화학식: C22H27ClN6O6S
- 분자량:539.00
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
CRL-42872 (1.5×10-8 M - 7×10-5 M; 3 minutes) potently inhibits collagen-induced aggregation of guinea pig platelets with an IC50 of 9.4×10-8 M[1].
CRL-42872 (10-8 M - 5×10-5 M; 3 minutes) inhibits collagen-induced aggregation of human platelets with an IC50 of 1.2×10-7 M[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Dunkin-Hartley (male, ~330 g)[1]
-
Dosage:10 mg/kg
-
Administration:p.o.; single dose
-
Result:Inhibited collagen-induced platelet aggregation by 68% at 1 hour post-administration.
Inhibited collagen-induced platelet aggregation by 64% at 2 hours post-administration.
Chemical Information
-
CAS No. 256385-24-7
-
분자량 539.00
-
화학식 C22H27ClN6O6S
-
SMILES
O=C1CN(C2=CC=C(C=C2)C(N)=N)CCN1CC(NC[C@@H](C(O)=O)NS(=O)(C3=CC=CC=C3)=O)=O.Cl
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)